PURPOSE Assessing measurable residual disease (MRD) has become standard with many tumors, but the clinical meaning of MRD in multiple myeloma (MM) remains uncertain, particularly when assessed by next ...

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study. JCO 31 , 2540-2547 (2013). DOI: ...

The upcoming webinar will delve into the advanced applications of Next Generation Flow™ in the analysis of Minimal Residual Disease (MRD) in Multiple Myeloma (MM). Dr. Juan Flores-Montero, a ...

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry. Haematologica ...

Clinical updates for August 2020 featured in Evidence-Based Oncology. MRD Should Be More Widely Used in Clinical Care of MM, Report Argues Advances in scientists' understanding of multiple myeloma ...

Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After. toggle ...

In part 2 of our interview with Surbhi Sidana, MD, MBBS, American Society of Hematology and Stanford University, she delves into one of the hottest topics in the hematologic malignancy space today ...

Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology, published online an analysis of patient samples from the Intergroupe Francophone du Myéloma ...

Darzalex addition to VRd improved MRD negativity and PFS in transplant-ineligible multiple myeloma patients. The CEPHEUS trial showed a 50% increase in MRD negativity with Darzalex, consistent across ...

The meta-analyses are based on findings from prior multiple myeloma trials and are designed to examine whether MRD negativity can be linked to positive patient outcomes, regardless of the therapy ...

If you have multiple myeloma, there’s a good chance it will come back after successful treatment.When this happens, it’s called recurrent or relapsed. If it doesn’t respond to treatment or ...